Fumihiko Hattanda

509 total citations
19 papers, 350 citations indexed

About

Fumihiko Hattanda is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Fumihiko Hattanda has authored 19 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Fumihiko Hattanda's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (11 papers), Vasculitis and related conditions (10 papers) and Genetic and Kidney Cyst Diseases (3 papers). Fumihiko Hattanda is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (11 papers), Vasculitis and related conditions (10 papers) and Genetic and Kidney Cyst Diseases (3 papers). Fumihiko Hattanda collaborates with scholars based in Japan and United Kingdom. Fumihiko Hattanda's co-authors include Tatsuya Atsumi, Utano Tomaru, Akihiro Ishizu, Daigo Nakazawa, Sakiko Masuda, Yoshihiro Kusunoki, Haruki Shida, Saori Nishio, Arina Miyoshi and Yuka Nishibata and has published in prestigious journals such as Kidney International, Frontiers in Immunology and Cell Reports.

In The Last Decade

Fumihiko Hattanda

17 papers receiving 341 citations

Peers

Countries citing papers authored by Fumihiko Hattanda

Since Specialization

Citations

This map shows the geographic impact of Fumihiko Hattanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Hattanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Hattanda more than expected).

Fields of papers citing papers by Fumihiko Hattanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihiko Hattanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Hattanda. The network helps show where Fumihiko Hattanda may publish in the future.

Co-authorship network of co-authors of Fumihiko Hattanda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiko Hattanda. A scholar is included among the top collaborators of Fumihiko Hattanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiko Hattanda. Fumihiko Hattanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis 2024 ·Kidney International ·(unknown), (unknown), Saori Nishio, (unknown), Takashi Kudo, (unknown), (unknown), Fumihiko Hattanda, Sari Iwasaki, Takahiro Tsuji, Utano Tomaru, Yasuaki Aratani, (unknown), Akihiro Ishizu, Tatsuya Atsumi	13
2	Tubulointerstitial nephritis with IgM-positive plasma cells complicated by liver failure 2024 ·CEN Case Reports ·Takashi Kudo, Daigo Nakazawa, Saori Nishio, Fumihiko Hattanda, (unknown), (unknown), (unknown), Sari Iwasaki, Takahiro Tsuji, Yasuni Nakanuma, Goki Suda, (unknown), Naoya Sakamoto, Tatsuya Atsumi	0
3	Inhibition of Toll-like receptor 4 and Interleukin-1 receptor prevent SARS-CoV-2 mediated kidney injury 2023 ·Cell Death Discovery ·Daigo Nakazawa, Yohei Takeda, Masatoshi Kanda, Utano Tomaru, Haruko Ogawa, Takashi Kudo, (unknown), (unknown), (unknown), (unknown), Fumihiko Hattanda, Saori Nishio, (unknown), Akihiro Ishizu, Tatsuya Atsumi	10
4	Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD 2023 ·Cell Reports ·Shin-Ichi Mae, Fumihiko Hattanda, Hiroyoshi Morita, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Akira Watanabe, Tomoyoshi Soga, Saori Nishio, Kenji Osafune	16
5	Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study 2022 ·Frontiers in Medicine ·(unknown), Daigo Nakazawa, Saori Nishio, (unknown), (unknown), (unknown), (unknown), Takashi Kudo, (unknown), (unknown), Junya Yamamoto, Naoko Matsuoka, (unknown), Fumihiko Hattanda, Sari Iwasaki, Takahiro Tsuji, Yuichiro Fukasawa, Tatsuya Atsumi	4
6	Transcriptional dynamics of granulocytes in direct response to incubation with SARS‐CoV‐2 2022 ·FEBS Open Bio ·(unknown), Yohei Takeda, Masatoshi Kanda, Utano Tomaru, Haruko Ogawa, Takashi Kudo, (unknown), (unknown), (unknown), (unknown), Fumihiko Hattanda, Saori Nishio, (unknown), Akihiro Ishizu, Tatsuya Atsumi	2
7	Initial experience with the use of tris-acryl gelatin microspheres for transcatheter arterial embolization for enlarged polycystic liver 2019 ·Clinical and Experimental Nephrology ·Yusuke Sakuhara, Saori Nishio, Fumihiko Hattanda, (unknown), (unknown), Daisuke Abo, Hidefumi Mimura	5
8	Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection 2019 ·Journal of Autoimmunity ·(unknown), Daigo Nakazawa, Yoshihiro Kusunoki, Takashi Kudo, Fumihiko Hattanda, Saori Nishio, Sakiko Masuda, Utano Tomaru, Takeshi Kondo, Tatsuya Atsumi, Akihiro Ishizu	18
9	The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis 2019 ·Lara D. Veeken ·Fumihiko Hattanda, Daigo Nakazawa, (unknown), Yoshihiro Kusunoki, Haruki Shida, Sakiko Masuda, Saori Nishio, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu	14
10	A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis 2019 ·Medicine ·(unknown), (unknown), Daigo Nakazawa, (unknown), Fumihiko Hattanda, Yuichiro Fujieda, Saori Nishio, Shinsuke Yasuda, Akihiro Ishizu, Tatsuya Atsumi	7
11	The Diagnostic and Clinical Utility of the Myeloperoxidase–DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis 2019 ·Otology & Neurotology ·Shinya Morita, Yuji Nakamaru, Daigo Nakazawa, Masanobu Suzuki, (unknown), Atsushi Fukuda, Fumihiko Hattanda, (unknown), Utano Tomaru, Akihiro Ishizu, Akihiro Homma	10
12	Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report 2018 ·BMC Nephrology ·Haruki Shida, Nobuhiro Hashimoto, Yoshihiro Kusunoki, Fumihiko Hattanda, Yayoi Ogawa, Terumasa Hayashi, Daigo Nakazawa, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu	9
13	Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis 2018 ·Cytometry Part A ·(unknown), (unknown), Haruki Shida, Yoshihiro Kusunoki, Fumihiko Hattanda, Shun Tanimura, (unknown), Mai Yamada, Yuka Nishibata, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu	3
14	SP027EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE STAGE CKD 2018 ·Nephrology Dialysis Transplantation ·Fumihiko Hattanda, Saori Nishio, (unknown), Tatsuya Atsumi	1
15	Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained From Patients With Otitis Media Associated With Antineutrophil Cytoplasmic Antibody-associated Vasculitis 2018 ·Otology & Neurotology ·Shinya Morita, Yuji Nakamaru, Daigo Nakazawa, Fumihiko Hattanda, Haruki Shida, Yoshihiro Kusunoki, Kanako Watanabe, Sakiko Masuda, Dai Takagi, Masanobu Suzuki, (unknown), Atsushi Fukuda, Utano Tomaru, Akihiro Homma, Akihiro Ishizu	6
16	Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease 2017 ·Kidney International ·Junya Yamamoto, Saori Nishio, Fumihiko Hattanda, (unknown), Tōru Kimura, Michio Sata, (unknown), (unknown), Tatsuya Atsumi	25
17	Measurement of NET formation in vitro and in vivo by flow cytometry 2017 ·Cytometry Part A ·Sakiko Masuda, (unknown), Junji Matsuo, Yuka Nishibata, Yoshihiro Kusunoki, Fumihiko Hattanda, Haruki Shida, Daigo Nakazawa, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu	95
18	Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production 2016 ·Frontiers in Immunology ·Yoshihiro Kusunoki, Daigo Nakazawa, Haruki Shida, Fumihiko Hattanda, Arina Miyoshi, Sakiko Masuda, Saori Nishio, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu	90
19	The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation 2016 ·Frontiers in Immunology ·Haruki Shida, Daigo Nakazawa, (unknown), Arina Miyoshi, Yoshihiro Kusunoki, Fumihiko Hattanda, Sakiko Masuda, Utano Tomaru, Tamihiro Kawakami, Tatsuya Atsumi, Akihiro Ishizu	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact